PINK1 and Parkin rescue motor defects and mitochondria dysfunction induced by a patient-derived HSPB3 mutant in Drosophila models
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.09.092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Ji Eun Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Dong-A University College of Medicine, Busan, 49201, South Korea; Department of Translational Biomedical Sciences, Dong-A…. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Drosophila Proteins, Heat-Shock Proteins, Small. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Korea Basic Science Institute, National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Small heat shock proteins (sHSPs) are ATP-independent molecular chaperones with the α-crystalline domain that is critical to their chaperone activity. Within the sHSP family, three (HSPB1, HSPB3, and HSPB8) proteins are linked with inherited peripheral neuropathies, including distal hereditary motor neuropathy (dHMN) and Charco-Marie-Tooth disease (CMT). In this study, we introduced the HSPB3 Y118H (HSPB3Y118H) mutant gene identified from the CMT2 family in Drosophila. With a missense mutation on its α-crystalline domain, this human HSPB3 mutant gene induced a loss of motor activity accompanied by reduced mitochondrial membrane potential in fly neuronal tissues. Moreover, mitophagy, a critical mechanism of mitochondrial quality control, is downregulated in fly motor neurons expressing HSPB3Y118H. Surprisingly, PINK1 and Parkin, the core regulators of mitophagy, successfully rescued these motor and mitochondrial abnormalities in HSPB3 mutant flies. Results from the first animal model of HSPB3 mutations suggest that mitochondrial dysfunction plays a critical role in HSPB3-associated human pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Dong-A University College of Medicine, Busan, 49201, South Korea; Department of Translational Biomedical Sciences, Dong-A University College of Medicine, Busan, 49201, South Korea.
- Department of Pharmacology, Dong-A University College of Medicine, Busan, 49201, South Korea; Neuroscience Translational Research Solution Center, Dong-A University College of Medicine, Busan, 49201, South Korea.
- Department of Biochemistry, Dong-A University College of Medicine, Busan, 49201, South Korea.
- Department of Neurology, SAIHST, Sungkyunkwan University School of Medicine, Seoul, 06351, South Korea.
- Department of Pharmacology, Dong-A University College of Medicine, Busan, 49201, South Korea; Department of Translational Biomedical Sciences, Dong-A University College of Medicine, Busan, 49201, South Korea; Neuroscien…
Förderung
- Korea Basic Science Institute
- National Research Foundation of Korea
- Ministry of Education
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Han, J. E., Kang, K. H., Kim, H., Hong, Y. B., Choi, B. O., & Koh, H. (2023). PINK1 and Parkin rescue motor defects and mitochondria dysfunction induced by a patient-derived HSPB3 mutant in Drosophila models. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.09.092
Vancouver
Han JE, Kang KH, Kim H, Hong YB, Choi BO, Koh H. PINK1 and Parkin rescue motor defects and mitochondria dysfunction induced by a patient-derived HSPB3 mutant in Drosophila models. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.09.092
BibTeX
@article{Han2023,
author = {Han, Ji Eun and Kang, Kyong-Hwa and Kim, Hyunjin and Hong, Young Bin and Choi, Byung-Ok and Koh, Hyongjong},
title = {PINK1 and Parkin rescue motor defects and mitochondria dysfunction induced by a patient-derived HSPB3 mutant in Drosophila models},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.09.092}
}
EUVIMED